Management of patients with heart failure and angina: Do coexistent diseases alter the response to cardiovascular drugs?
- 1 March 1991
- journal article
- editorial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 17 (3) , 740-742
- https://doi.org/10.1016/s0735-1097(10)80193-7
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Effect of Captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failureJournal of the American College of Cardiology, 1991
- The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: A dangerous imbalance in the risk-benefit ratioAmerican Heart Journal, 1989
- Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hopeJournal of the American College of Cardiology, 1988
- Effects of ouabain and isoproterenol on left ventricular diastolic function during low-flow ischemia in isolated, blood-perfused rabbit hearts.Circulation Research, 1988
- Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique.Circulation, 1988
- Reduction in digitalis-associated postinfarction mortality with nadolol in conscious dogsAmerican Heart Journal, 1988
- Lack of reflex increase in myocardial sympathetic tone after captopril: potential antianginal effect.Circulation, 1985
- Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.Circulation, 1982
- Heart Failure in OutpatientsNew England Journal of Medicine, 1982
- Digitalis-associated cardiac mortality after myocardial infarction.Circulation, 1981